• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Critical Care Needs in Patients with Diffusion-Weighted Imaging Negative MRI after tPA--Does One Size Fit All?组织型纤溶酶原激活剂治疗后磁共振成像扩散加权像阴性患者的重症监护需求——一种方案适用于所有情况吗?
PLoS One. 2015 Oct 30;10(10):e0141204. doi: 10.1371/journal.pone.0141204. eCollection 2015.
2
Predictors of critical care needs after IV thrombolysis for acute ischemic stroke.急性缺血性卒中静脉溶栓后重症监护需求的预测因素。
PLoS One. 2014 Feb 12;9(2):e88652. doi: 10.1371/journal.pone.0088652. eCollection 2014.
3
Presence of deep white matter lesions on diffusion-weighted imaging is a negative predictor of early dramatic improvement after intravenous tissue plasminogen activator thrombolysis.弥散加权成像上存在深部白质病变是静脉注射组织型纤溶酶原激活物溶栓后早期显著改善的负预测因子。
Cerebrovasc Dis. 2010 Aug;30(3):230-6. doi: 10.1159/000317183. Epub 2010 Jul 1.
4
Migraine History: A Predictor of Negative Diffusion-Weighted Imaging in IV-tPA-Treated Stroke Mimics.偏头痛病史:IV-tPA 治疗的卒中样发作模拟物中弥散加权成像呈阴性的预测因素。
J Stroke Cerebrovasc Dis. 2019 Nov;28(11):104282. doi: 10.1016/j.jstrokecerebrovasdis.2019.06.040. Epub 2019 Aug 8.
5
Large ischemic lesions on diffusion-weighted imaging done before intravenous tissue plasminogen activator thrombolysis predicts a poor outcome in patients with acute stroke.在静脉注射组织纤溶酶原激活剂溶栓治疗前进行的弥散加权成像上出现大面积缺血性病变,预示急性中风患者预后不良。
Stroke. 2008 Aug;39(8):2388-91. doi: 10.1161/STROKEAHA.107.510917. Epub 2008 Jun 5.
6
Intravenous Thrombolysis Increases the Rate of Dramatic Recovery in Patients with Acute Stroke with an Unknown Onset Time and Negative FLAIR MRI.静脉溶栓可提高急性起病时间不明且FLAIR MRI阴性的急性卒中患者显著恢复的比例。
J Neuroimaging. 2016 Jul;26(4):414-9. doi: 10.1111/jon.12323. Epub 2015 Dec 21.
7
Pretreatment diffusion-weighted imaging lesion volume predicts favorable outcome after intravenous thrombolysis with tissue-type plasminogen activator in acute ischemic stroke.治疗前弥散加权成像病灶体积可预测急性缺血性脑卒中患者接受组织型纤溶酶原激活物静脉溶栓后的良好结局。
Stroke. 2011 May;42(5):1251-4. doi: 10.1161/STROKEAHA.110.600148. Epub 2011 Mar 17.
8
Tissue plasminogen activator thrombolytic therapy for acute ischemic stroke in 4 hospital groups in Japan.日本 4 家医院组织中的组织型纤溶酶原激活物溶栓治疗急性缺血性脑卒中。
J Stroke Cerebrovasc Dis. 2013 Apr;22(3):190-6. doi: 10.1016/j.jstrokecerebrovasdis.2011.07.016. Epub 2011 Oct 2.
9
Monitoring intravenous recombinant tissue plasminogen activator thrombolysis for acute ischemic stroke with diffusion and perfusion MRI.使用扩散加权成像和灌注加权成像监测静脉注射重组组织型纤溶酶原激活剂治疗急性缺血性卒中的溶栓过程。
Stroke. 2000 Jun;31(6):1318-28. doi: 10.1161/01.str.31.6.1318.
10
ICU Interventions in Ischemic Stroke Patients Treated Using Liberalized IV-tPA Criteria.采用宽松静脉注射组织型纤溶酶原激活剂标准治疗的缺血性中风患者的重症监护病房干预措施
J Stroke Cerebrovasc Dis. 2019 Sep;28(9):2488-2495. doi: 10.1016/j.jstrokecerebrovasdis.2019.06.015. Epub 2019 Jul 3.

引用本文的文献

1
Stroke Hospitalization Administration & Monitoring: Routine or COVID-19 Care (SHAMROCC).中风住院管理与监测:常规护理或新冠护理(SHAMROCC)
Neurohospitalist. 2025 May 2:19418744251338601. doi: 10.1177/19418744251338601.
2
Shorter Intensive Care Unit Stay (12 Hours) Post Thrombolysis Is Safe and Reduces Length of Stay for Minor Stroke Patients.溶栓后缩短重症监护病房停留时间(12小时)对轻度中风患者是安全的,并可缩短住院时间。
Neurohospitalist. 2022 Jul;12(3):504-507. doi: 10.1177/19418744211048014. Epub 2022 Feb 23.
3
Practices and Patterns of Hourly Neurochecks: Analysis of 8,936 Patients With Neurological Injury.神经小时检查的实践和模式:8936 例神经损伤患者的分析。
J Intensive Care Med. 2022 Jun;37(6):784-792. doi: 10.1177/08850666211029220. Epub 2021 Jul 5.
4
Safety Trial of Low-Intensity Monitoring After Thrombolysis: Optimal Post Tpa-Iv Monitoring in Ischemic STroke (OPTIMIST).溶栓后低强度监测的安全性试验:缺血性卒中的最佳组织型纤溶酶原激活剂静脉注射后监测(OPTIMIST)。
Neurohospitalist. 2020 Jan;10(1):11-15. doi: 10.1177/1941874419845229. Epub 2019 May 5.

本文引用的文献

1
Predictors of critical care needs after IV thrombolysis for acute ischemic stroke.急性缺血性卒中静脉溶栓后重症监护需求的预测因素。
PLoS One. 2014 Feb 12;9(2):e88652. doi: 10.1371/journal.pone.0088652. eCollection 2014.
2
Serum creatinine may indicate risk of symptomatic intracranial hemorrhage after intravenous tissue plasminogen activator (IV tPA).血清肌酐可能提示静脉注射组织型纤溶酶原激活剂(IV tPA)后出现症状性颅内出血的风险。
Medicine (Baltimore). 2013 Nov;92(6):317-323. doi: 10.1097/MD.0000000000000006.
3
IV thrombolysis and renal function.静脉溶栓治疗和肾功能。
Neurology. 2013 Nov 12;81(20):1780-8. doi: 10.1212/01.wnl.0000435550.83200.9e. Epub 2013 Oct 11.
4
Negative diffusion-weighted imaging after intravenous tissue-type plasminogen activator is rare and unlikely to indicate averted infarction.静脉注射组织型纤溶酶原激活物后出现弥散受限为阴性的情况很少见,且不太可能表明梗死被逆转。
Stroke. 2013 Jun;44(6):1629-34. doi: 10.1161/STROKEAHA.111.000486. Epub 2013 Apr 9.
5
Safety of thrombolysis in stroke mimics: results from a multicenter cohort study.溶栓治疗酷似脑卒中患者的安全性:一项多中心队列研究结果。
Stroke. 2013 Apr;44(4):1080-4. doi: 10.1161/STROKEAHA.111.000126. Epub 2013 Feb 26.
6
Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.急性缺血性脑卒中患者早期管理指南:美国心脏协会/美国卒中协会医疗保健专业人员指南。
Stroke. 2013 Mar;44(3):870-947. doi: 10.1161/STR.0b013e318284056a. Epub 2013 Jan 31.
7
Safety of Intravenous Thrombolysis within 4.5 h of symptom onset in patients with negative post-treatment stroke imaging for cerebral infarction.脑梗死患者治疗后影像学检查阴性时,症状发作后 4.5 h 内静脉溶栓的安全性。
Neurocrit Care. 2011 Aug;15(1):76-9. doi: 10.1007/s12028-011-9523-x.
8
Reduced estimated glomerular filtration rate is associated with stroke outcome after intravenous rt-PA: the Stroke Acute Management with Urgent Risk-Factor Assessment and Improvement (SAMURAI) rt-PA registry.估算肾小球滤过率降低与静脉注射 rt-PA 后卒中结局相关:卒中急性管理伴紧急风险因素评估和改善(SAMURAI)rt-PA 登记研究。
Cerebrovasc Dis. 2011;31(2):123-9. doi: 10.1159/000321516. Epub 2010 Nov 17.
9
Safety of tPA in stroke mimics and neuroimaging-negative cerebral ischemia.tPA 在卒中模拟和神经影像学阴性脑缺血中的安全性。
Neurology. 2010 Apr 27;74(17):1340-5. doi: 10.1212/WNL.0b013e3181dad5a6. Epub 2010 Mar 24.
10
Transient ischemic attack after tissue plasminogen activator: aborted stroke or unnecessary stroke therapy?组织型纤溶酶原激活物治疗后发生短暂性脑缺血发作:中止性卒中还是不必要的卒中治疗?
Cerebrovasc Dis. 2010;29(1):57-61. doi: 10.1159/000255975. Epub 2009 Nov 5.

组织型纤溶酶原激活剂治疗后磁共振成像扩散加权像阴性患者的重症监护需求——一种方案适用于所有情况吗?

Critical Care Needs in Patients with Diffusion-Weighted Imaging Negative MRI after tPA--Does One Size Fit All?

作者信息

Faigle Roland, Marsh Elisabeth B, Llinas Rafael H, Urrutia Victor C

机构信息

Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America.

出版信息

PLoS One. 2015 Oct 30;10(10):e0141204. doi: 10.1371/journal.pone.0141204. eCollection 2015.

DOI:10.1371/journal.pone.0141204
PMID:26517543
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4627762/
Abstract

BACKGROUND AND PURPOSE

Patients who receive intravenous (IV) tissue plasminogen activator (tPA) for ischemic stroke are currently monitored in an intensive care unit (ICU) or a comparable stroke unit for at least 24 hours due to the high frequency of neurological exams and vital sign checks. The present study evaluates ICU needs in patients with diffusion-weighted imaging (DWI) negative MRI after IV tPA.

METHODS

A retrospective chart review was performed for 209 patients who received IV tPA for acute stroke. Data on stroke risk factors, physiologic parameters, stroke severity, MRI characteristics, and final diagnosis were collected. The timing and nature of ICU interventions, if needed, was recorded. Multivariable logistic regression was used to determine factors associated with subsequent ICU needs.

RESULTS

Patients with cerebral infarct on MRI after tPA had over 9 times higher odds of requiring ICU care compared to patients with DWI negative MRI (OR 9.2, 95% CI 2.49-34.15). All DWI negative patients requiring ICU care did so by the end of tPA infusion (p = 0.006). Among patients with DWI negative MRI, need for ICU interventions was associated with higher NIH Stroke Scale (NIHSS) scores (p<0.001), uncontrolled hypertension (p<0.001), seizure at onset (p = 0.002), and reduced estimated glomerular filtration rate (eGFR) (p = 0.010).

CONCLUSIONS

Only a small number of DWI negative patients required ICU care. In patients without critical care needs by the end of thrombolysis, post-tPA MRI may be considered for triaging DWI negative patients to a less resource intense monitoring environment.

摘要

背景与目的

由于神经学检查和生命体征检查的频率较高,目前接受静脉注射组织型纤溶酶原激活剂(tPA)治疗缺血性卒中的患者需在重症监护病房(ICU)或类似的卒中单元监测至少24小时。本研究评估静脉注射tPA后磁共振扩散加权成像(DWI)阴性的患者对ICU的需求。

方法

对209例接受静脉注射tPA治疗急性卒中的患者进行回顾性病历审查。收集卒中危险因素、生理参数、卒中严重程度、MRI特征和最终诊断的数据。记录ICU干预的时间和性质(如有需要)。采用多变量逻辑回归确定与后续ICU需求相关的因素。

结果

与DWI阴性MRI的患者相比,tPA治疗后MRI显示脑梗死的患者需要ICU护理的几率高出9倍以上(比值比9.2,95%置信区间2.49 - 34.15)。所有需要ICU护理的DWI阴性患者在tPA输注结束时均如此(p = 0.006)。在DWI阴性MRI的患者中,需要ICU干预与较高的美国国立卫生研究院卒中量表(NIHSS)评分(p<0.001)、未控制的高血压(p<0.001)、发病时癫痫发作(p = 0.002)和估计肾小球滤过率(eGFR)降低(p = 0.010)相关。

结论

只有少数DWI阴性患者需要ICU护理。对于溶栓结束时无重症监护需求的患者,tPA治疗后的MRI可考虑用于将DWI阴性患者分流至资源需求较少的监测环境。